Methodological considerations in D-health cancer mortality results

Affiliations

¹ The Daffodil Centre, University of Sydney and Cancer Council NSW, Sydney, NSW 2011, Australia. Electronic address: samuel.egger@sydney.edu.au.
² The Daffodil Centre, University of Sydney and Cancer Council NSW, Sydney, NSW 2011, Australia.

Comment

Sam Egger et al. Lancet Diabetes Endocrinol. 2022 May.

. 2022 May;10(5):307.

doi: 10.1016/S2213-8587(22)00109-7.

¹ The Daffodil Centre, University of Sydney and Cancer Council NSW, Sydney, NSW 2011, Australia. Electronic address: samuel.egger@sydney.edu.au.
² The Daffodil Centre, University of Sydney and Cancer Council NSW, Sydney, NSW 2011, Australia.

No abstract available

Conflict of interest statement

SE, DPS, and VN-S report grants paid to The Daffodil Centre from the Prostate Cancer Foundation of Australia.

Methodological considerations in D-health cancer mortality results - Authors' reply.
Neale RE, Romero BD, McLeod DSA, English DR, Hartel G, van der Pols JC, Venn AJ, Webb PM, Whiteman DC, Waterhouse M. Neale RE, et al. Lancet Diabetes Endocrinol. 2022 May;10(5):307-308. doi: 10.1016/S2213-8587(22)00107-3. Lancet Diabetes Endocrinol. 2022. PMID: 35461531 No abstract available.

The D-Health Trial: a randomised controlled trial of the effect of vitamin D on mortality.
Neale RE, Baxter C, Romero BD, McLeod DSA, English DR, Armstrong BK, Ebeling PR, Hartel G, Kimlin MG, O'Connell R, van der Pols JC, Venn AJ, Webb PM, Whiteman DC, Waterhouse M. Neale RE, et al. Lancet Diabetes Endocrinol. 2022 Feb;10(2):120-128. doi: 10.1016/S2213-8587(21)00345-4. Epub 2022 Jan 10. Lancet Diabetes Endocrinol. 2022. PMID: 35026158 Clinical Trial.